Broccoli design offers clue to improve retinal implants

Researchers at the University of Oregon are currently exploring the possibility that retinal implants with a fractal design might provide the first viable therapy in treating people who have lost vision due to retinal diseases. Implants that are currently being used have not demonstrated the kind of vision restoration that doctors and patients were looking […]

Retinal detachment linked to certain antibiotics

Antibiotics known as fluoroquinolones must now carry a warning that the drugs may cause retinal detachment, says the Canadian Health Department. The decision comes after researchers at the University of British Columbia determined that the risk of retinal detachment is five times more likely among patients taking a fluoroquinolone. Researchers had first raised the concern […]

Consumer Alert – .gov site unreliable source of legitimate drug trials

ClinicalTrials.gov, that the public listing of medical trials on the site is not a list of trials that have been verified as legitimate by the National Institutes of Health. The National Institutes of Health is the agency that operates ClinicalTrials.gov. People tend to assume that any trials listed on ClinicalTrials.gov have been carefully screened and […]

New Treatment for Damaged Eyes

Researchers at the University of Washington have discovered a way to activate retinal cells in mice to turn into new neurons. This discovery could potentially lead to new a new treatment for human eyes that have suffered from trauma or disease. A viral gene-swapping technique was used in the study. A version of a particular […]

Some new drugs pose risk to vision

Three immune drugs, Yervoy, Opdivo, and Keytruda, may require warning labels if the FDA decides that there are risks to eye health and vision. Currently, the drugs list “uveitis” as a potential adverse effect, but the FDA has found additional complications including retinal detachment and vision loss in their post-marketing reviews of the drugs. A […]

New drug for Macular Degeneration

Genetech is currently studying a new drug, lampalizumab, to treat age-related macular degeneration. The drug is designed to slow the destruction of light-sensing cells in the retina. When those cells die, they are unable to regenerate, which causes permanent vision loss. 129 patients participated in the 18-month study and received monthly eye injections. The patients […]

Study warns of unregulated clinics

A recent study published in the journal Cell¬†warns of a growing number of unregulated clinics in the United States offering unregulated stem cell treatments. This alarming trend has eye care professionals urging consumers to be on alert. The unregulated clinics are able to skirt FDA oversight all because of a technicality. These clinics take cells […]

Eye care providers not always detecting AMD

A recent study found that many times, primary eye care providers are missing cases of age-related macular degeneration. After reviewing data on 1,288 eyes in patients who received a dilated eye exam and who were not diagnosed with macular degeneration, researchers had retina specialists take another look and macular degeneration was diagnosed in 25 percent […]

#1 Cause of Vision Loss in Adults? Diabetes.

Diabetic retinopathy is the #1¬†cause of vision loss among working adults between the ages of 20 and 74 in the United States.* Lucentis recently gained FDA approval for monthly treatment of every form of diabetic retinopathy. This marks the first drug that the FDA has approved to treat diabetic retinopathy “with or without diabetic macular […]

Hep C raises risk for cataracts

Study findings published in PLoS One show patients suffering from hepatitis C (HCV) infection have an increased risk of developing cataracts. Researchers from China Medical University Hospital in Tiachung, Taiwan wanted to investigate whether HCV infection was associated with a higher risk of cataract formation. Researchers analyzed database records of 11,652 patients with HCV and […]